Friday, 16 October 2026European Markets

ACOMO And UNILEVER Have A High Dividend Yield And Return On Equity In The Consumer Defensive Sector.

Loading stream...

(VIANEWS) - ACOMO (ACOMO.AS) is among this list of stock assets with the highest dividend rate and return on equity on the Consumer Defensive sector.

Financial Asset Price Forward Dividend Yield Return on Equity
ACOMO (ACOMO.AS) €17.62 6.83% 11.27%
UNILEVER (UNA.AS) €43.51 3.9% 39.9%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. ACOMO (ACOMO.AS)

6.83% Forward Dividend Yield and 11.27% Return On Equity

Acomo N.V., together with its subsidiaries, engages in sourcing, trading, processing, packaging, and distributing conventional and organic food ingredients and solutions for the food and beverage industry worldwide. It operates through five segments: Spices and Nuts, Edible Seeds, Organic Ingredients, Tea, and Food Solutions. The Spices and Nuts segment provides tropical products, including pepper, nutmeg, desiccated coconut, shelled and unshelled nuts, dried fruits, dehydrated vegetables, herbs, rice crackers, and snack products. Its Edible Seeds segment trades, processes, and distributes edible seeds, such as poppy, sesame, pumpkin, and flax, as well as sunflower seeds comprising in-kernel and shelled for the snack and retail industries; birdseeds for wildlife; and edible seeds to bakery, spice, and confectionery industries. The Organic Ingredients segment provides a range of organic food products and ingredients in various categories, including cocoa, coffee, fruit and vegetables, edible seeds, nuts and dried fruits, oils, and premium juice products. Its Tea segment trades, processes, and distributes through warehouses and blending facilities; and monitors and analyzes market development, and shares insight to customers to meet traditional consumer preferences, which include novel appetites for specialty tea. The Food Solutions segment produces and supplies culinary and functional ingredients, plant-based solutions, wet and dry blends, and spice mixes to food companies; and provides product development, manufacturing, packaging, distribution, and inventory management services. The company was formerly known as Amsterdam Commodities N.V. and changed its name to Acomo N.V. in June 2022. Acomo N.V. was founded in 1908 and is based in Rotterdam, the Netherlands.

Earnings Per Share

As for profitability, ACOMO has a trailing twelve months EPS of €1.55.

PE Ratio

ACOMO has a trailing twelve months price to earnings ratio of 11.37. Meaning, the purchaser of the share is investing €11.37 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.27%.

Volume

Today's last reported volume for ACOMO is 12293 which is 39.66% below its average volume of 20374.

More news about ACOMO.

2. UNILEVER (UNA.AS)

3.9% Forward Dividend Yield and 39.9% Return On Equity

Unilever PLC operates as a fast-moving consumer goods company. It operates through Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream segments. The Beauty & Wellbeing segment engages in the sale of hair care products, such as shampoo, conditioner, and styling; skin care products including face, hand, and body moisturizer; and prestige beauty and health & wellbeing products, which includes the vitamins, minerals, and supplements. Personal Care segment offers skin cleansing products comprising soap and shower, deodorant and oral care products, such as toothpaste, toothbrush, and mouthwash products. Home Care segment engages in the sale of fabric care including washing powders and liquids, and rinse conditioners; and home and hygiene, fabric enhancers, water and air wellness products. Nutrition segment provides the sale of scratch cooking aids, which includes soups, bouillons, and seasonings; dressings products, such as mayonnaise and ketchup; and beverages and functional nutrition products including Horlicks and Boost, as well as tea products. Ice Cream segment offers ice cream products including in-home and out-of-home ice creams. It offers its products under the AXE, Bango, Ben & Jerry's, Cif, Comfort, Domestos, Dove, Equilibra, Hellmann's, Knorr, LUX, Lifebuoy, Liquid I.V., Love Beauty & Planet, Magnum, OLLY, OMO, Onnit, Rexona, Seventh Generation, SmartPants, Sunsilk, The Vegetarian Butcher, Vaseline, and Wall's brands. The company was founded in 1860 and is headquartered in London, the United Kingdom.

Earnings Per Share

As for profitability, UNILEVER has a trailing twelve months EPS of €3.26.

PE Ratio

UNILEVER has a trailing twelve months price to earnings ratio of 13.35. Meaning, the purchaser of the share is investing €13.35 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 39.9%.

More news about UNILEVER.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com